Caliway Biopharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	9,027	3,422	655.05	594.91	93.56	21.69
Short-Term Investments	667.4	289.4	456.18	-	-	-
Cash & Short-Term Investments	9,694	3,712	1,111	594.91	93.56	21.69
Cash Growth	-	234.01%	86.79%	535.87%	331.36%	-
Accounts Receivable	12.69	7.89	3.12	-	-	3.2
Other Receivables	-	-	-	-	-	4.46
Receivables	12.69	7.89	3.12	-	-	7.66
Inventory	2.96	1.02	2.81	0.05	2.53	0.02
Other Current Assets	20.17	23.16	14.87	10.32	14.96	9.08
Total Current Assets	9,730	3,744	1,132	605.27	111.05	38.45
Property, Plant & Equipment	68.41	80.41	99.6	106.38	114.68	128.99
Other Intangible Assets	-	-	-	-	0.07	1.66
Other Long-Term Assets	3.28	2.46	1.46	1.26	1.26	1.26
Total Assets	9,801	3,827	1,233	712.9	227.05	170.35
Accounts Payable	4.33	1.7	2.53	0.33	0.74	1.04
Accrued Expenses	-	-	-	30.98	45.14	19.96
Short-Term Debt	-	-	-	-	-	5
Current Portion of Long-Term Debt	-	-	-	1.17	7.97	74.72
Current Portion of Leases	8.83	8.58	8.22	7.03	6.79	6.49
Current Unearned Revenue	4.51	1.03	4.5	-	-	-
Other Current Liabilities	47.32	62.37	33.11	0.16	3.82	3.2
Total Current Liabilities	65	73.68	48.36	39.67	64.45	110.4
Long-Term Debt	-	-	-	3.55	83.95	30.41
Long-Term Leases	5.23	11.87	20.46	25.02	32.06	38.85
Total Liabilities	70.23	85.55	68.82	68.24	180.46	179.66
Common Stock	767.19	696.62	615.55	535.93	312.17	244.71
Additional Paid-In Capital	9,495	3,271	834.46	217.47	106.85	18.6
Retained Earnings	-532.69	-227.31	-286.16	-107.41	-371.05	-272.56
Treasury Stock	-	-0.07	-0.08	-0.09	-	-
Comprehensive Income & Other	1.62	0.81	0.49	-1.24	-1.38	-0.06
Shareholders' Equity	9,731	3,741	1,164	644.66	46.6	-9.31
Total Liabilities & Equity	9,801	3,827	1,233	712.9	227.05	170.35
Total Debt	14.07	20.46	28.68	36.78	130.76	155.46
Net Cash (Debt)	9,680	3,691	1,083	558.13	-37.2	-133.77
Net Cash Growth	-	240.96%	93.96%	-	-	-
Net Cash Per Share	71.11	29.79	9.24	6.07	-0.50	-1.91
Filing Date Shares Outstanding	153.44	139.3	123.11	107.16	83.29	69.92
Total Common Shares Outstanding	153.44	139.3	123.11	107.16	83.29	69.92
Working Capital	9,665	3,670	1,084	565.6	46.6	-71.96
Book Value Per Share	63.42	26.86	9.46	6.02	0.56	-0.13
Tangible Book Value	9,731	3,741	1,164	644.66	46.53	-10.96
Tangible Book Value Per Share	63.42	26.86	9.46	6.02	0.56	-0.16
Machinery	138.4	129.99	121.55	112.76	76.42	74.25
Construction In Progress	0.05	1.14	1.82	0.3	31.29	31.67

Source: S&P Capital IQ. Standard template. Financial Sources.